abstract |
For example, 5,5-fused heteroarylene hepatitis C virus inhibitor compounds of formula I, IA or IB, pharmaceutical compositions comprising the same, and methods of making the same are provided. Also provided are methods of use for the treatment of HCV infection in a host in need thereof. Formula (I), (IA), (IB) |